Normal function · from ai-gene-review (Q9GZX6, commit 79fe13b38970) · AI-generated, not KB evidence

Interleukin-22 (IL-22) is a secreted cytokine of the IL-10 family that plays critical roles in innate immunity, tissue repair, and inflammation at barrier surfaces. Unlike most cytokines, IL-22 acts primarily on non-immune cells (epithelial cells, hepatocytes) through the IL-22R1/IL-10RB receptor complex, activating JAK-STAT signaling to promote antimicrobial defense, epithelial proliferation, and tissue regeneration. IL-22 is produced mainly by activated T cells (Th17/Th22) and innate lymphoid cells (ILC3) in response to infection and inflammation. Its activity is tightly regulated by the soluble antagonist IL-22BP (IL-22RA2), creating a balanced system essential for maintaining barrier integrity while preventing excessive tissue responses.

Interleukin-22 receptor binding activates JAK-STAT signaling in epithelial cells to induce antimicrobial peptide production
Cytokine activity stimulates hepatocyte acute phase protein synthesis through STAT3 activation
molecular function: cytokine activity · directly involved in: acute-phase response; inflammatory response · locations: extracellular region
Interleukin-22 receptor binding promotes epithelial cell proliferation and tissue repair at barrier surfaces
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Bacterial meningitis no genetic record
mechanism: Blood-Brain Barrier Disruption
Chronic Mucocutaneous Candidiasis no genetic record
mechanism: Deficient IL-17A, IL-17F and IL-22 Production

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.